Genetics and genomics of pseudoexfoliation syndrome/glaucoma

Middle East African Journal of Ophthalmology

Volumn 18, Issue 1, 2011, Pages 30-36

  Schlotzer Schrehardt, Ursula ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Complex Genetics; LOXL1; Pseudoexfoliation Glaucoma; Pseudoexfoliation Syndrome

Indexed keywords

APOLIPOPROTEIN E2; ARGININE; ASPARTIC ACID; CLUSTERIN; CONTACTIN ASSOCIATED LIKE PROTEIN 2; EYE PROTEIN; FIBRILLIN 1; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; GLYCINE; LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN 2; LEUCINE; LYSYL OXIDASE LIKE 1; MICROFIBRIL ASSOCIATED PROTEIN 2; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; PROTEIN LYSINE 6 OXIDASE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; DOWN REGULATION; ENZYME ACTIVITY; ENZYME SPECIFICITY; FUNCTIONAL GENOMICS; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC RISK; GENETIC VARIABILITY; GLAUCOMA; HUMAN; MOLECULAR PATHOLOGY; NONHUMAN; PENETRANCE; POPULATION DIFFERENTIATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PSEUDOEXFOLIATION; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION;

EID: 79953048686     PISSN: 09749233     EISSN: 09751599     Source Type: Journal    
DOI: 10.4103/0974-9233.75882     Document Type: Article

References (70)

1. Ritch R, Schltzer-Schrehardt U. Exfoliation syndrome. Surv Ophthalmol 2001;45:265-315.
2. Ritch R. Exfoliation syndrome: The most common identifiable cause of open-angle glaucoma. J Glaucoma 1994;3:176-8. (Pubitemid 24179802)
3. Bialasiewicz AA, Wali U, Shenoy R, Al-Saeidi R. Patients with secondary open-angle glaucoma in pseudoexfoliation (PEX) syndrome among a population with high prevalence of PEX: Clinical findings and morphological and surgical characteristics. Ophthalmologe 2005;102:1064-8. (Pubitemid 41625908)
4. Ritch R, Schltzer-Schrehardt U, Konstas AG. Why is glaucoma associated with exfoliation syndrome? Progr Ret Eye Res 2003;22:253-75. (Pubitemid 38401056)
5. Leskea MC, Heijl A, Hyman L, Bengtsson B, Komaroff E. Factors for progression and glaucoma treatment: The Early Manifest Glaucoma Trial. Curr Opin Ophthalmol 2004;15:102-6. (Pubitemid 38457128)
6. Naumann GO, Schltzer-Schrehardt U, Kchle M. Pseudoexfoliation syndrome for the comprehensive ophthalmologist. Intraocular and systemic manifestations. Ophthalmology 1998;105:951-68. (Pubitemid 28268316)
7. Conway RM, Schltzer-Schrehardt U, Kchle M, Naumann GO. Pseudoexfoliation syndrome: Pathologic manifestations of relevance to intraocular surgery. Clin Exp Ophthalmol 2004;32:199-210. (Pubitemid 38618411)
8. Schltzer-Schrehardt U, Naumann GO. Perspective-Ocular and systemic pseudoexfoliation syndrome. Am J Ophthalmol 2006;141:921-37.
9. Zenkel M, Pschl E, von der Mark K, Hofmann-Rummelt C, Naumann GO, Kruse FE, et al. Differential gene expression in pseudoexfoliation syndrome. Invest Ophthalmol Vis Sci 2005;46:3742-52.
10. Zenkel M, Lewczuk P, Jnemann A, Kruse FE, Naumann GO, Schltzer-Schrehardt U. Pro-inflammatory cytokines are involved in initiation of the abnormal matrix process in pseudoexfoliation syndrome/glaucoma. Am J Pathol 2010;176:2868-79.
11. Zenkel M, Kruse FE, Naumann GO, Schltzer-Schrehardt U. Impaired cellular stress response in eyes with pseudoexfoliation syndrome/glaucoma. Invest Ophthalmol Vis Sci 2007;48:5558-66. (Pubitemid 351260857)
12. Ovodenko B, Rostagno A, Neubert TA, Shetty V, Thomas S, Yang A, et al. Proteomic analysis of exfoliation deposits. Invest Ophthalmol Vis Sci 2007;48:1447-57. (Pubitemid 351261324)
13. Sharma S, Chataway T, Burdon KP, Jonavicius L, Klebe S, Hewitt AW, et al. Identification of LOXL1 protein and apolipoprotein E as components of surgically isolated pseudoexfoliation material by direct mass spectrometry. Exp Eye Res 2009;89:479-85.
14. Damji KF, Bains HS, Stefansson E, Loftsdottir M, Sverrisson T, Thorgeirsson E, et al. Is pseudoexfoliation syndrome inherited? A review of genetic and nongenetic factors and a new observation. Ophthalmic Genet 1998;19:175-85. (Pubitemid 29021153)
15. Orr AC, Robitaille JM, Price PA, Hamilton JR, Falvey DM, De Saint-Sardos AG, et al. Exfoliation syndrome: Clinical and genetic features. Opthalmic Genet 2001;22:171-85. (Pubitemid 34248304)
16. Forsman E, Cantor RM, Lu A, Eriksson A, Fellman J, Jrvel I, et al. Exfoliation syndrome: Prevalence and inheritance in a subisolate of the Finnish population. Acta Ophthalmol Scand 2007;85:500-7.
17. Wiggs JL. Association between LOXL1 and pseudoexfoliation. Arch Ophthalmol 2008;126:420-1. (Pubitemid 351398471)
18. Lemmel S, Forsman E, Sistonen P, Eriksson A, Forsius H, Jrvel I. Genome-wide scan of exfoliation syndrome. Invest Ophthalmol Vis Sci 2007;48:4136-42. (Pubitemid 351261040)
19. Thorleifsson G, Magnusson KP, Sulem P, Walters GB, Gudbjartsson DF, Stefansson H, et al. Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma. Science 2007;317:1397-400. (Pubitemid 47417481)
20. Chen H, Chen LJ, Zhang M, Gong W, Tam PO, Lam DS, et al. Ethnicity-based subgroup meta-analysis of the association of LOXL1 polymorphisms with glaucoma. Mol Vis 2010;16:167-77.
21. Fingert JH, Alward WL, Kwon YH, Wang K, Streb LM, Sheffield VC, et al. LOXL1 mutations are associated with exfoliation syndrome in patients from the Midwestern United States. Am J Ophthalmol 2007;144:974-5.
22. Aragon-Martin JA, Ritch R, Liebmann J, OBrien C, Blaaow K, Mercieca F, et al. Evaluation of LOXL1 gene polymorphisms in exfoliation syndrome and exfoliation glaucoma. Mol Vis 2008;14:533-41. (Pubitemid 351472358)
23. Challa P, Schmidt S, Liu Y, Qin X, Vann RR, Gonzalez P, et al. Analysis of LOXL1 polymorphisms in a United States population with pseudoexfoliation glaucoma. Mol Vis 2008;14:146-9. (Pubitemid 351193745)
24. Fan BJ, Pasquale L, Grosskreutz CL, Rhee D, Chen T, DeAngelis MM, et al. DNA sequence variants in the LOXL1 gene are associated with pseudoexfoliation glaucoma in a U.S. clinic-based population with broad ethnic diversity. BMC Med Genet 2008;9:5.
25. Yang X, Zabriskie NA, Hau VS, Chen H, Tong Z, Gibbs D, et al. Genetic association of LOXL1 gene variants and exfoliation glaucoma in a Utah cohort. Cell Cycle 2008;7:521-4. (Pubitemid 351366482)
26. Hewitt AW, Sharma S, Burdon KP, Wang JJ, Baird PN, Dimasi DP, et al. Ancestral LOXL1 variants are associated with pseudoexfoliation in Caucasian Australians but with markedly lower penetrance than in Nordic people. Hum Mol Genet 2008;17:710-6. (Pubitemid 351292259)
27. Mossbck G, Renner W, Faschinger C, Schmut O, Wedrich A, Weger M. Lysyl oxidase-like protein 1 (LOXL1) gene polymorphisms and exfoliation glaucoma in a Central European population. Mol Vis 2008;14:857-61. (Pubitemid 351699495)
28. Pasutto F, Krumbiegel M, Mardin CY, Paoli D, Lmmer R, Weber BH, et al. Association of LOXL1 common sequence variants in German and Italian patients with pseudoexfoliation syndrome and pseudoexfoliation glaucoma. Invest Ophthalmol Vis Sci 2008;49:1459-63.
29. Lemmel S, Forsman E, Onkamo P, Nurmi H, Laivuori H, Kivel T, et al. Association of LOXL1 gene with Finnish exfoliation syndrome patients. J Hum Gen 2009;54:289-97.
30. Holl G, Gl A, Kthy P, Molnr JM. LOXL1 gene sequence variants and vascular disease in exfoliation syndrome and exfoliative glaucoma. J Glaucoma 2010 in press.
31. Fuse N, Miyazawa A, Nakazawa T, Mengkegale M, Otomo T, Nishida K. Evaluation of LOXL1 polymorphisms in eyes with exfoliation glaucoma in Japanese. Mol Vis 2008;14:1338-43.
32. Hayashi H, Gotoh N, Ueda Y, Nakanishi H, Yoshimura N. Lysyl oxidase-like 1 polymorphisms and exfoliation syndrome in the Japanese population. Am J Ophthalmol 2008;145:582-5.
33. Mabuchi F, Sakurada Y, Kashiwagi K, Yamagata Z, Iijima H, Tsukahara S. Lysyl oxidase-like 1 gene polymorphisms in Japanese patients with primary open angle glaucoma and exfoliation syndrome. Mol Vis 2008;14:1303-8. (Pubitemid 352025119)
34. Mori K, Imai K, Matsuda A, Ikeda Y, Naruse S, Hitora-Takeshita H, et al. LOXL1 genetic polymorphisms are associated with exfoliation glaucoma in the Japanese population. Mol Vis 2008;14:1037-40. (Pubitemid 351843800)
35. Ozaki M, Lee KY, Vithana EN, Yong VH, Thalamuthu A, Mizoguchi T, et al. Association of LOXL1 gene polymorphisms with pseudoexfoliation in the Japanese. Invest Ophthalmol Vis Sci 2008;49:3976-80.
36. Tanito M, Minami M, Akahori M, Kaidzu S, Takai Y, Ohira A, et al. LOXL1 variants in elderly Japanese with exfoliation syndrome/glaucoma, primary open-angle glaucoma, normal tension glaucoma, and cataract. Mol Vis 2008;14:1898-905.
37. Chen L, Jia L, Wang N, Tang G, Zhang C, Fan S, et al. Evaluation of LOXL1 polymorphisms in exfoliation syndrome in a Chinese population. Mol Vis 2009;15:2349-57.
38. Lee KY, Ho SL, Thalamuthu A, Venkatraman A, Venkataraman D, Pek DC, et al. Association of LOXL1 polymorphisms with pseudoexfoliation in the Chinese. Mol Vis 2009;15:1120-6.
39. Ramprasad VL, George R, Soumittra N, Sharmila F, Vijaya L, Kumaramanickavel G. Association of non-synonymous single nucleotide polymorphisms in the LOXL1 gene with pseudoexfoliation syndrome in India. Mol Vis 2008;14:318-22. (Pubitemid 351279917)
40. Kuhlenbumer G, Friedrichs F, Kis B, Berlit P, Maintz D, Nassenstein I, et al. Association between single nucleotide polymorphisms in the lysyl oxidase-like 1 gene and spontaneous cervical artery dissection. Cerebrovasc Dis 2007;24:343-8.
41. Challa P. Genetics of pseudoexfoliation syndrome. Curr Opin Ophthalmol 2009;20:88-91.
42. Williams SE, Whigham BT, Liu Y, Carmichael TR, Qin X, Schmidt S, et al. Major LOXL1 risk allele is reversed in exfoliation glaucoma in a black South African population. Mol Vis 2010;16:705-12.
43. Csiszar K. Lysyl oxidases: A novel multifunctional amine oxidase family. Prog Nucleic Acid Res Mol Biol 2001;70:1-32. (Pubitemid 33804681)
44. Liu X, Zhao Y, Gao J, Pawlyk B, Starcher B, Spencer JA, et al. Elastic fiber homeostasis requires lysyl oxidase-like 1 protein. Nat Genet 2004;36:178-82. (Pubitemid 38174378)
45. Thomassin L, Werneck CC, Broekelmann TJ, Gleyzal C, Hornstra IK, Mecham RP, et al. The pro-regions of lysyl oxidase and lysyl oxidase-like 1 are required for deposition onto elastic fibers. J Biol Chem 2005;280:42848-55. (Pubitemid 43049247)
46. Schltzer-Schrehardt U, Pasutto F, Sommer P, Hornstra I, Kruse FE, Naumann GO, et al. Genotype-correlated expression of LOXL1 in ocular tissues of patients with pseudoexfoliation syndrome/glaucoma and normal subjects. Am J Pathol 2008;173:1724-35.
47. Schltzer-Schrehardt U, von der Mark K, Sakai LY, Naumann GO. Increased extracellular deposition of fibrillin-containing fibrils in pseudoexfoliation syndrome. Invest Ophthalmol Vis Sci 1997;38:970-84. (Pubitemid 27193523)
48. Schltzer-Schrehardt U. Molecular pathology of pseudoexfoliation syndrome/glaucoma - New insights from LOXL1 gene associations. Exp Eye Res 2009;88:776-85.
49. Netland PA, Ye H, Streeten BW, Hernandez MR. Elastosis of the lamina cribrosa in pseudoexfoliation syndrome with glaucoma. Ophthalmology 1995;102:878-86.
50. Krumbiegel M, Pasutto F, Mardin CY, Weisschuh N, Paoli D, Gramer E, et al. Exploring functional candidate genes for genetic association in German patients with pseudoexfoliation syndrome and pseudoexfoliation glaucoma. Invest Ophthalmol Vis Sci 2009;50:2796-801.
51. Burdon KP, Sharma S, Hewitt AW, McMellon AE, Wang JJ, Mackey DA, et al. Genetic analysis of the clusterin gene in pseudoexfoliation syndrome. Mol Vis 2008;14:1727-36.
52. Zenkel M, Kruse FE, Jnemann AG, Naumann GO, Schltzer-Schrehardt U. Deficiency of the extracellular chaperone clusterin in eyes with pseudoexfoliation syndrome may be implicated in the aggregation and deposition of pseudoexfoliative material. Invest Ophthalmol Vis Sci 2006;47:1982-90. (Pubitemid 46768279)
53. Fan BJ, Figuieredo S, Pasquale LR, Grosskreutz CL, Rhee DJ, Chen TC, et al. Lack of association of polymorphisms in elastin with pseudoexfoliation syndrome and glaucoma. J Glaucoma 2010;19:432-6.
54. Schltzer-Schrehardt U, Lommatzsch J, Kchle M, Konstas AG, Naumann GO. Matrix metalloproteinases and their inhibitors in aqueous humor of patients with pseudoexfoliation syndrome, pseudoexfoliation glaucoma, and primary open-angle glaucoma. Invest Ophthalmol Vis Sci 2003;44:1117-25. (Pubitemid 36300758)
55. Tsironi EE, Pefkianaki M, Tsezou A, Kotoula MG, Dardiotis E, Almpanidou P, et al. Evaluation of MMP1 and MMP3 gene polymorphisms in exfoliation syndrome and exfoliation glaucoma. Mol Vis 2009;15:2890-5.
56. Fan BJ, Chen T, Grosskreutz C, Pasquale L, Rhee D, DelBono E, et al. Lack of association of polymorphisms in homocysteine metabolism genes with pseudoexfoliation syndrome and glaucoma. Mol Vis 2008;14:2484-91.
57. Al-Dabbagh NM, Al-Dohayan N, Arfin M, Tariq M. Apolipoprotein E polymorphisms and primary glaucoma in Saudis. Mol Vis 2009;15:912-9.
58. Yilmaz A, Tamer L, Ates NA, Camdeviren H, Degirmenci U. Effects of apolipoprotein E genotypes on the development of exfoliation syndrome. Exp Eye Res 2005;80:871-5. (Pubitemid 40798053)
59. Ritland JS, Utheim TP, Utheim OA, Espeseth T, Lydersen S, Semb SO, et al. Effects of APOE and CHRNA4 genotypes on retinal nerve fibre layer thickness at the optic disc and on risk for developing exfoliation syndrome. Acta Ophthalmol Scand 2007;85:257-61. (Pubitemid 46711361)
60. Krumbiegel M, Pasutto F, Mardin CY, Weisschuh N, Paoli D, Gramer E, et al. Apolipoprotein E genotypes in pseudoexfoliation syndrome and pseudoexfoliation glaucoma. J Glaucoma 2010;19:561-5.
61. Abu-Amero KK, Morales J, Mohamed GH, Osman MN, Bosley TM. Glutathione S-transferase M1 and T1 polymorphisms in Arab glaucoma patients. Mol Vis 2008;14:425-30. (Pubitemid 351377323)
62. Yilmaz A, Tamer L, Ates NA, Yildirim O, Yildirim H, Atik U. Is GST gene polymorphism a risk factor in developing exfoliation syndrome? Curr Eye Res 2005;30:575-81. (Pubitemid 41113560)
63. Yuce H, Hepsen IF, Tekedereli I, Keskin U, Elyas H, Akyol O. Lack of association between pseudoexfoliation syndrome and manganese superoxide dismutase polymorphism. Curr Eye Res 2007;32:387-91. (Pubitemid 46633861)
64. Razeghinejad MR, Rahat F, Kamali-Sarvestani E. Association of TNFA-308 G/A and TNFRI +36 A/G gene polymorphisms with glaucoma. Ophthalmic Res 2009;42:118-24.
65. Khan MI, Micheal S, Rana N, Akhtar F, den Hollander AI, Ahmed A, et al. Association of tumor necrosis factor alpha gene polymorphism G-308A with pseudoexfoliative glaucoma in the Pakistani population. Mol Vis 2009;15:2861-7.
66. Tekeli O, Turacli ME, Egin Y, Akar N, Elhan AH. Tumor necrosis factor alpha-308 gene polymorphism and pseudoexfoliation glaucoma. Mol Vis 2008;14:1815-8.
67. Mossbck G, Renner W, El-Shabrawi Y, Faschinger C, Schmut O, Wedrich A, et al. TNF-a-308G>A and -238G>A polymorphisms are not major risk factors in Caucasian patients with exfoliation glaucoma. Mol Vis 2009;15:518-22.
68. Tekeli O, Turacli ME, Altinok B, Akar N, Elhan AH. No relation between angiotensin-converting enzyme gene polymorphism and pseudoexfoliation. Ophthalm Res 2008;40:32-32.
69. Abu-Amero KK, Bosley TM, Morales J. Analysis of nuclear and mitochondrial genes in patients with pseudoexfoliation glaucoma. Mol Vis 2008;14:29-36.
70. Wolf C, Gramer E, Mller-Myhsok B, Pasutto F, Wissinger B, Weisschuh N. Mitochondrial haplogroup U is associated with a reduced risk to develop exfoliation glaucoma in the German population. BMC Genet 2010;11:8.